Yusuke Kawasaki

Dr. Yusuke Kawasaki

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2026 in Japanese Journal of Radiology
Verified
Journal Article
Open access
PDF file
YKYusuke Kawasaki
Yusuke Kawasaki
MNMaika Nakajima
Maika Nakajima
KYKota Yokoyama
Kota Yokoyama
EYEmi Yamaga
Emi Yamaga
MKMakoto Kato
Makoto Kato
UTUkihide Tateishi
Ukihide Tateishi
Purpose: This study investigated whether contrast enhanced whole-body photon-counting detector (PCD)-CT performed for staging in the prone position can provide breast lesion conspicuity comparable to dynamic contrast-enhanced T1-weighted imaging (DCE-T1WI). Methods: This single-center, retrospective diagnostic feasibility study included 22 women with surgically confirmed primary breast cancer who underwent preoperative prone PCD-CT and DCE-MRI. Then, 40- and 70-keV virtual monoenergetic image (VMI) from a single arterial-phase PCD-CT acquisition were reconstructed. Three readers independently evaluated 40- and 70-keV VMI and DCE-T1WI. The primary endpoint was lesion conspicuity. The secondary endpoints included, size error, detection rate, background parenchymal enhancement (BPE), subjective noise, and reading time. Results: Lesion conspicuity was highest on 40-keV VMI, which outperformed 70-keV VMI and DCE-T1WI. Absolute size error was numerically larger for 40-keV VMI than for DCE-T1WI, but this difference was not statistically significant. Directional error indicated that 40-keV VMI significantly underestimated lesion size relative to DCE-T1WI. Detection rates showed an overall difference among modalities, but pairwise differences were not statistically significant. Further, 40-keV VMI had a higher BPE and a greater perceived noise than 70-keV VMI, and it required a longer reading time than DCE-T1WI. The radiation dose did not differ between VMI energy levels as both were reconstructed from the same acquisition. Conclusion: Arterial-phase 40-keV VMIs from prone PCD-CT demonstrated the highest lesion conspicuity and showed better detection capability than 70-keV VMI. In addition, their performance was comparable to or superior to DCE-T1WI. This finding was achieved despite trade-offs in increased noise, BPE and size underestimation. Thus, 40-keV VMI may serve as a useful complementary modality for local breast assessment and may be considered a potential alternative for lesion localization when MRI is not feasible, despite potential underestimation of lesion extent.

15 November 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
MWMomo Wakui
Momo Wakui
KYKota Yokoyama
Kota Yokoyama
HYHirofumi Yamada
Hirofumi Yamada
YKYusuke Kawasaki
Yusuke Kawasaki
HHHiroto Hada
Hiroto Hada
UTUkihide Tateishi
Ukihide Tateishi
Background/Objectives: Pulmonary iodine maps are routinely available from photon-counting detector computed tomography (PCD-CT), including examinations not optimized for pulmonary embolism (PE) assessment. We evaluated the frequency and contrast-phase distribution of pulmonary iodine map defects in routine clinical practice. Methods: This retrospective single-center study included 442 contrast-enhanced PCD-CT examinations in 433 patients during March–April 2026, each with whole-lung coverage in at least one postcontrast phase. Examinations were classified as dedicated pulmonary arterial, other whole-lung arterial, or nonarterial-only imaging. Two radiologists independently reviewed iodine maps followed by 70-keV virtual monoenergetic images, with disagreements resolved by consensus. Analyses were descriptive; no independent reference standard was available. Results: Iodine map defects were identified in 4/442 examinations (0.9%; 95% confidence interval, 0.2–2.3%), all corresponding to pulmonary arterial filling defects interpreted as PE. Defects occurred in 2/15 dedicated pulmonary arterial examinations and 2/70 other arterial examinations, versus 0/357 nonarterial-only examinations. In all three iodine-defect-positive examinations with paired later-phase imaging, iodine defects were no longer visible. Overall, PE was identified in 6/442 examinations (1.4%), including three findings absent from the original reports. Interobserver agreement was κ = 0.86 for iodine defects and κ = 0.83 for PE. Conclusions: Arterial-phase iodine maps may provide clues to PE on routine PCD-CT, even when acquisition is not timed to the pulmonary arterial phase. Absence of iodine defects on nonarterial images should not be used to exclude PE. Larger studies are needed to establish diagnostic benefit.